We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors.
- Authors
Candelaria, Myrna; Gallardo-Rincón, Dolores; Arce, Claudia; Cetina, Lucely; Aguilar-Ponce, Jose Luis; Arrieta, Oscar; Serrano, Alberto; Perez-Plasencia, Carlos; Gonzalez-Fierro, Aurora; De la Cruz-Hernandez, Erik; Revilla-Vazquez, Alma; Chavez-Blanco, Alma; Trejo-Becerril, Catalina; Perez-Cardenas, Enrique; Taja-Chayeb, Lucia; Camargo, Maria F.; Robles, Elizabeth; Dueñas-Gonzalez, Alfonso
- Abstract
An abstract of the article "A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors," by Myrna Candelaria, Claudia Arce, Oscar Arrieta, Alberto Serrano, and colleagues is presented.
- Subjects
DRUG therapy
- Publication
BMC Cancer, 2007, Vol 7, pA27
- ISSN
1471-2407
- Publication type
Abstract
- DOI
10.1186/1471-2407-7-S1-A27